Infusion of di-2-ethylhexylphthalate for neonates: A review of potential health risk

Journal of Infusion Nursing

Volumn 28, Issue 1, 2005, Pages 54-60

  Jaeger, Rudolph J ^a,b   Weiss, Arlene L ^b,c   Brown, Karen ^d  

^a Environmental Medicine Inc   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PharmTox ^*

^d B Braun Medical

Author keywords

[No Author keywords available]

Indexed keywords

PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PLASTICIZER; POLYVINYLCHLORIDE;

DRUG SAFETY; DRUG TOLERABILITY; HEALTH HAZARD; HUMAN; INFUSION; INTENSIVE CARE UNIT; NEWBORN; NEWBORN CARE; PRIORITY JOURNAL; REVIEW; TOXICITY TESTING;

EID: 13644255951     PISSN: 15331458     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129804-200501000-00007     Document Type: Review

References (47)

1. Zimmerman JA, Ballard JM, Wang H, Wu A, Gallagher KA. Extraction of o-phenylphenol from silicone tubing by a sulfobutylether cyclodextrin formulation. Int J Pharmaceut. 2003; 267(1-2):113-120.
2. Jaeger RJ. Studies on the Extraction, Accumulation, and Metabolism of Phthalate Ester Plasticizers from Polyvinly chloride Medical Devices. Ann Arbor Mich: University Microfilm; 1971:2-139.
3. Hanawa T, Endoh N, Kazuno F, et al. Investigation of the release behavior of diethylhexyl phthalate from polyvinyl chloride tubing for intravenous administration based on HCO60. Int J Pharm. 2003;267(1-2):141-149.
4. NTP-CERHR Expert Panel. Report on Di(2-ethylhexyl)phthalate). NTP-CERHR Expert Panel Report 2000; NTP-CERHR-DEHP-00:1-115. Available at: http://cerhr.niehs.nih.gov.
5. Akingbemi BT, Ge RS, Klinefelter GR, Zirkin BR, Hardy MP. Phthalate-induced Leydig cell hyperplasia is associated with multiple endocrine disturbances. Proc Nat Acad Sci U S A. 2004;101(3): 775-780.
6. Jaeger RJ, Rubin RJ. Contamination of blood stored in plastic packs. Lancet. 1970;151.
7. Jaeger RJ, Rubin RJ. Migration of a phthalate ester plasticizer from polyvinyl chloride blood bags into stored human blood and its localization in human tissues. N Engl J Med. 1972;287(22): 1114-1118.
8. Perinatal profiles: Statistics for monitoring state maternal and infant health. 2003. Available at: www.marchofdimes.com. Accessed July 23, 2003.
9. Preterm birth. 2003. Available at: www.marchofdimes.com. Accessed July 23, 2003.
10. Congenital heart disease. 2003. Available at: www.chop.edu. Accessed July 23, 2003.
11. Kim ES, Stolar CJ. Ecmo in the newborn. Am J Perinatol. 2000; 7(7):345-356.
12. WHO. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer. Lyon, France: World Health Organization; 1987; 1-42:355 and 357:355.
13. WHO. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer. Lyon, France: World Health Organization; 1987; 1-42:355 and 357:355.
14. Tickner JA, Schettler T, Guidotti T, McCally M, Ross M. Health risks posed by use of di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: a critical review. Am J Ind Med. 2001;39:100-111.
15. Production: slow gains in output of chemicals and products lagged behind U.S. economy as a whole. 2001. C&EN. Available at: www.pubs.acs.org/cen. Accessed June 25, 2001.
16. Huber WW, Grasl-Kraupp B, Schulte-Hermann R. Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Crit Rev Toxicol. 1996;26(4):365-481.
17. Feigal DW. Public Health Notification: PVC Devices Containing the Plasticizer DEHP. Washington, DC: Department of Health & Human Services; 2002;1-4.
18. Koch HM, Drexler H, Angerer J. An estimation of the daily intake of di(2-ethylhexyl)phthalate (DEPH) and other phthalates in the general population. Int J Hyg Environ Health. 2003;206: 77-83.
19. SjobergP, Bondesson U, Sedin G, Gustafsson J. Dispositions of di- and mono-(2-ethylhexyl)phthalate in newborn infants subjected to exchange transfusions. Eur J Clin Invest. 1985;15:430-436.
20. FDA CEDRH. Safety Assessment of Di(2-ethylhexyl)phthalate (DEHP) Released from PVC Medical Devices. Rockville, Md: FDA CEDRH 2003;1-118.
21. Calafat AM, Needham LL, Silva MJ, Lambert G. Exposure to di-(2-ethylhexyl)phthalate among premature neonates in a neonatal intensive care unit. Pediatrics. 2004;113(5):e429-434.
22. Rozman KK, Doull J. Dose and time as variables of toxicity. Toxicology. 2000;144(1-3):169-178.
23. Jacobson MS, Kevy SV, Grand RJ. Effects of a plasticizer leached from polyvinyl chloride on the subhuman primate: a consequence of chronic transfusion therapy. J Lab Clin Med. 1975;89(5):1066-1079.
24. European Commission. Opinion On: Medical Devices Containing DEHP Plasticised PVC; Neonates and Other Groups Possibly at Risk from DEHP Toxicity. Brussels: European Commission; 2002;1-34.
25. Wilson VS, Lambright C, Furr J, et al. Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rat testis. Toxicol Lett. 2004;146(3):207-215.
26. Li H, Kim KH. Effects of mono-(2-ethylhexyl)phthalate on fetal and neonatal rat testis organ cultures. Biol Reprod. 2003;69(6): 1964-1972.
27. Kato K, Silva MJ, Reidy JA, et al. Mono(2-ethyl-5-hydroxyhexyl)phthalate and mono-(2-ethyl-5-oxohexyl)phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. Environ Health Perspect. 2004;112(3):327-330.
28. Silva MJ, Barr DB, Reidy JA, et al. Urinary levels of seven phthalate metabolites in the US Population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect. 2004;112(3):331-338.
29. Koch HM, Drexler H, Angerer J. Internal exposure of nursery-school children and their parents and teachers to di(2-ethylhexyl)phthalate (DEHP). Int J Hyg Environ Health. 2004;207(1): 15-22.
30. Jacobson MS, Kevy SV, Grand RJ. Effects of a plasticizer leached from polyvinyl chloride on the subhuman primate: a consequence of chronic transfusion therapy. J Lab Clin Med. 1977;89(5):1066-1079.
31. Hillman LS, Goodwin SL, Sherman WR. Identification and measurement of plasticizer in neonatal tissues after umbilical catheters and blood products. N Engl J Med. 1975;292(8):381-386.
32. Sjoberg P, Bondesson U, Gray TJB, Ploen L. Effects of di-(2-ethylhexyl)phthalate and five of its metabolites on rat testis in vivo and in vitro. Acta Pharmacol Et Toxicol. 1986;58:225-233.
33. Li LH, Jester WF, Orth JM. Effects of relatively low levels of mono-(2-ethylhexyl)phthalate on cocultured sertoli cells and gonocytes from neonatal rats. Toxicol Appl Pharmacol. 1998;153:258-265.
34. Teirlynck O, Kaufman JM, Bogaert MG, Roels H. Testicular toxicity induced by single dosing of di- and mono-(2-ethylhexyl)phthalate in the rat. Toxicol Lett. 1988;40:85-91.
35. David RM, Moore MR, Finney DC, Guest D. Reversibility of the chronic effects of di(2-ethylhexyl)phthalate. Toxicol Pathol. 2001;29(4):430-439.
36. Kurata Y, Kidachi F, Yokoyama M, Toyota N, Tsuchitani M, Katoh M. Subchronic toxicity of di(2-ethylhexyl)phthalate in common marmosets: lack of hepatic peroxisome proliferation, testicular atrophy, or pancreatic acinar cell hyperplasia. Toxicol Sci. 1998;42:49-56.
37. Kurata Y, Makinodan F, Okada M, et al. Blood concentration and tissue distribution of 14c-di(2-ethylhexyl)phthalate (DEHP) in juvenile and adult common marmoset. Society Toxicol Toxicologist. 2003;72(S-1):384-385.
38. Tomonari Y, Kurata Y, Kawasuso T, et al. Testicular toxixity study of di(2-ethylhexyl)phthalate (DEHP) in juvenile common marmoset. Society Toxicol Toxicologist. 2003;72(S-1):385.
39. Roth B, Herkenrath P, Lehmann HJ, et al. Di-(2-ethylhexyl)-phthalate as plasticizer in PVC respiratory tubing systems: indications of hazardous effects on pulmonary function in mechanically ventilated, preterm infants. Eur J Pediatr. 1988;147:41-46.
40. Latini G, Avery GB. Materials degradation in endotracheal tubes: a potential contributor to bronchopulmonary dysplasia. Acta Paediatr. 1999;88:1174-1175.
41. Cicognani A, Alessandroni R, Pasini A, et al. Low birth weight for gestational age and subsequent male gonadal function. J Pediatr. 2002;141(3):376-380.
42. Rais-Bahrami K, Nunez S, Ravenis ME, Luban NLC, Short BL. Follow -up study of adolescents exposed to di-2-ethylhexylphthalate (DEHP) as neonates on extracorporeal membrane oxygenation (ECMO) support. Environmental Health Perspectives, 2004; 112(13):1339-1340.
43. Duty SM, Silva MJ, Barr DB, et al. Phthalate exposure and human semen parameters. Epidemiology. 2003;14(3):269-277.
44. Duty SM, Singh NP, Silva MJ, et al. The relationship between environmental exposures to phthalates and DNA damage in human sperm using the neutral comet assay. Environ Health Perspect. 2003;111(9):1164-1169.
45. Health Canada Expert Advisory Panel. Summary of the 2002 Report of the Health Canada Expert Advisory Panel on DEHP in Medical Devices. Health Canada Expert Advisory Panel. 2002; 1-6.
46. Mckee RH, Butala JH, David RM, Gans G. NTP Center for the Evaluation of Risks to Human Reproduction reports on phthalates: addressing the data gaps. Reprod Toxicol. 2004;18(1):1-22.
47. Kavlock R, Boekelheide K, Chapin R, et al. NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di(2-ethylhexyl)phthalate. Reprod Toxicol. 2002;16(5):529-653.